FDA Inspection
ANSTO Nuclear MedicineANSTO Nuclear Medicine – FDA Inspection, Apr 17, 2019
Record Details
This FDA Inspection record concerns ANSTO Nuclear Medicine, with an inspection on April 17, 2019, issued by the Office of Inspections and Investigations, covering human drugs.
View Company Profile
ID · 23f144bf-5de2-4762-91a1-4e032443ff68
Inspection Facts
- Inspection number
- 1086494
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of ANSTO Nuclear Medicine
3| Date | Classification | Office | Project area |
|---|---|---|---|
| June 24, 2022 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 4, 2016 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 14, 2009 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for ANSTO Nuclear Medicine
- FDA Inspection 1175112 - 2022-06-24
- FDA Inspection 962746 - 2016-02-04
- FDA Inspection 612118 - 2009-08-14
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.